Carmustine
Carmustine is a generic chemotherapy drug used to treat certain cancers, such as brain tumors and Hodgkin's lymphoma. It comes as an injectable solution in 100mg vials, marketed by Navinta LLC under ANDA210179. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Carmustine is a generic chemotherapy drug used to treat certain cancers, such as brain tumors and Hodgkin's lymphoma. It comes as an injectable solution in 100mg vials, marketed by Navinta LLC under ANDA210179. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Carmustine",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Carmustine — ANDA 213207 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213207"
}
]
|
| identifier | ANDA213207 |
| issued | 2016-09-16 |
| keyword |
[
"drug-information",
"health-care",
"medications",
"pharmaceuticals",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Carmustine |
